Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway.

• University of Ibadan (NG)

• University of Fort Hare (ZA)

tal como impresso: Ishmael Jaja

• University of Ibadan (NG)

• University of Ibadan (NG)

tal como impresso: Olumayowa Igado

• University of Ibadan (NG)

• Federal College of Animal Health and Production Technology Ibadan (NG)

tal como impresso: Taiwo Oyagbemi

• University of Ibadan (NG)

tal como impresso: Oluwaseun Esan

• Federal College of Animal Health and Production Technology Ibadan (NG)

tal como impresso: Omolola Awoyomi

• University of Ibadan (NG)

• University of Ibadan (NG)

tal como impresso: Ifeoluwa Awogbindin